Nasonex News

• Schering-Plough Reports Financial Results for Second Quarter of 2008 (PR Newswire via Yahoo! Finance)
  Schering-Plough Corporation today reported financial results for the second quarter of 2008.



• Nielsen IAG: Drug Spots Lose Potency (AdWeek)
  NEW YORK If you think that marketing in the drug category is becoming less interesting and more monotonous, you're right.



• Global Climate Change May Spur Seasonal Sniffles (Palatka Daily News)
  (ARA) - Many scientists now believe that global climate change is affecting various aspects of human health, including nasal allergies.



• Back-to-school tips for kids with asthma, allergies (Chicago Tribune)
  



• Drug Ads Losing Recall Effectiveness Among Consumers (BrandWeek)
  If you think that marketing in the drug category is becoming less interesting and more monotonous, you're right. A ranking of the most-recalled prescription drug ads shows that prescription drug ads became less memorable for consumers between this year and last, as measured by Nielsen IAG, New York.



• Focus on the Schering-Plough Corporation: PharmaVitae Profile (Marketwire via Yahoo! Finance)
  Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue.



• Schering-Plough 2Q profit falls on charges (phillyburbs.com)
  NEW YORK - Schering-Plough Corp.'s second-quarter profit tumbled 23 percent on charges for a canceled development program with Merck & Co. and accounting adjustments, but adjusted profit topped Wall Street forecast.



• Schering-Plough Profit Dips on Cholesterol Pill Sales (Update2) (Bloomberg.com)
  July 21 (Bloomberg) -- Schering-Plough Corp. said profit fell 19 percent as new products and job cuts failed to offset falling sales of cholesterol pills Zetia and Vytorin.